GT Molecular, a company providing ultrasensitive PCR assays and national testing services for wastewater-based epidemiology, cancer, and pathogens, is releasing a series of high-performance Respiratory Panels and Polio Typing Assays for several major PCR platforms.
| Multiplexed SARS-CoV-2, Influenza A/B, and RSV and Poliovirus Typing Assays (1, 2 and 3) for the Bio-Rad, QIAGEN, and Thermo PCR Platforms FORT COLLINS, Colo., Dec. 20, 2022 /PRNewswire/ -- GT Molecular, a company providing ultrasensitive PCR assays and national testing services for wastewater-based epidemiology, cancer, and pathogens, is releasing a series of high-performance Respiratory Panels and Polio Typing Assays for several major PCR platforms.
Respiratory Panels and Polio Assays optimized for the following digital PCR and RT-PCR Platforms:
Clinical Research Multiplexed Respiratory RT-qPCR Kit (Research Use Only):
Wastewater-Based Epidemiology (WBE) PCR Kits:
National digital PCR and NGS Service for a growing list of pathogens in wastewater:
GT Molecular is empowering hundreds of academic, commercial, and public testing laboratories around the world with its easy-to-use and accurate PCR assay kits and its national testing and sequencing services. About GT Molecular GT Molecular is a leader in providing highly customizable, ultrasensitive, digital PCR and RT-qPCR tests and wastewater-based testing services. GTM’s patent-pending assay technology provides a user friendly, out-of-box solution for rapid deployment and yields reliable and consistent measurements while detecting as little as 3 molecules of target nucleic acid. The company has a growing catalog of molecular assays that includes SARS-CoV-2 multi-variant tests, cancer panels, and multiplexed pathogen panels. ORDER & INFORMATION: info@gtmolecular.com
SOURCE GT Molecular |
View original content to download multimedia:
